Ascletis Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2020
Market Capitalization	17,081	2,904	1,522	5,153	3,575	3,154	Upgrade
Market Cap Growth	976.69%	90.74%	-70.46%	44.13%	13.38%	-4.03%	Upgrade
Enterprise Value	15,117	665	-1,197	2,236	435	-134	Upgrade
Last Close Price	17.74	3.01	1.46	4.74	3.29	2.87	Upgrade
PS Ratio	6593.86	2126.81	24.42	84.27	37.89	75.87	Upgrade
PB Ratio	8.35	1.39	0.59	1.80	1.07	0.89	Upgrade
P/TBV Ratio	8.39	1.40	0.60	1.81	1.10	0.92	Upgrade
EV/Sales Ratio	-	486.91	-	36.57	4.61	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00	Upgrade
Asset Turnover	0.00	0.00	0.02	0.02	0.03	0.01	Upgrade
Inventory Turnover	0.27	0.11	2.30	2.05	0.66	1.02	Upgrade
Quick Ratio	14.36	12.82	16.50	23.24	28.26	37.47	Upgrade
Current Ratio	14.57	12.88	16.58	23.52	28.93	38.36	Upgrade
Return on Equity (ROE)	-12.78%	-13.97%	-5.93%	-11.95%	-6.97%	-6.64%	Upgrade
Return on Assets (ROA)	-12.32%	-10.96%	-7.50%	-7.94%	-4.88%	-4.79%	Upgrade
Return on Capital (ROIC)	-12.96%	-11.70%	-7.89%	-8.26%	-5.04%	-4.93%	Upgrade
Earnings Yield	-1.66%	-11.03%	-10.47%	-6.91%	-6.83%	-7.88%	Upgrade
FCF Yield	-2.01%	-12.60%	-16.64%	-4.60%	-5.21%	-3.38%	Upgrade
Buyback Yield / Dilution	6.20%	6.75%	1.19%	0.96%	-5.53%	1.37%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.